PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Benzoyl peroxide and clindamycin phosphate
Presentation Product Chemical substance Chapter Items dispensed
Benzoyl peroxide 5% / Clindamycin 1% gel
1306010Y0AAAAAA
Benzoyl peroxide/clindamycin phosphate Benzoyl peroxide and clindamycin phosphate Skin 71,204
Duac Once Daily gel (5% and 1%)
1306010Y0BBAAAA
Duac Benzoyl peroxide and clindamycin phosphate Skin 29,514
Benzoyl peroxide 3% / Clindamycin 1% gel
1306010Y0AAABAB
Benzoyl peroxide/clindamycin phosphate Benzoyl peroxide and clindamycin phosphate Skin 26,918
Duac Once Daily gel (3% and 1%)
1306010Y0BBABAB
Duac Benzoyl peroxide and clindamycin phosphate Skin 17,792

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.